Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.06 USD | -3.47% | -4.08% | +7.75% |
09/05 | Transcript : DiaMedica Therapeutics Inc., Q1 2024 Earnings Call, May 09, 2024 | |
17/04 | DiaMedica Therapeutics Launches Late-Stage Trial of Potential Stroke Treatment | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.75% | 12Cr | |
+9.58% | 11TCr | |
+12.41% | 11TCr | |
-2.59% | 2.2TCr | |
-12.38% | 2.19TCr | |
-5.29% | 1.92TCr | |
-3.35% | 1.81TCr | |
-38.57% | 1.77TCr | |
+7.51% | 1.43TCr | |
+35.67% | 1.24TCr |
- Stock Market
- Equities
- DMAC Stock
- News DiaMedica Therapeutics Inc.
- Maxim Group Adjusts DiaMedica Therapeutics Price Target to $6 From $11, Maintains Buy Rating